CIIE looks to continue opening-up policy entornointeligente.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from entornointeligente.com Daily Mail and Mail on Sunday newspapers.
Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q3 2022 Earnings Conference Call November 03, 2022, 04:30 PM ET Company Participants Arvind Sood - VP, IR Bob Bradway - Chairman and CEO Peter Griffith - CFO.
Amgen’s drug portfolio boasts several biologic drugs that are blockbuster sellers. In acquiring ChemoCentryx for $3.7 billion, the pharmaceutical giant gains a company entirely focused on developing small molecule alternatives to biologic medicines.
Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q1 2022 Results Conference Call April 27, 2022 05:00 PM ET Company Participants Arvind Sood - VP, IR Bob Bradway - Chairman and CEO Peter Griffith - CFO.